ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pertussis Vaccination Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-6N13442
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Pertussis Vaccination Market Research Report 2023
BUY CHAPTERS

Global Pertussis Vaccination Market Research Report 2025

Code: QYRE-Auto-6N13442
Report
January 2025
Pages:78
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma
KM Biologics
Wuhan Institute of Biological Products
Walvax Biotechnology
Chengdu Institute of Biological Products
Minhai Biotechnology

Pertussis Vaccination Market Size

The global market for Pertussis Vaccination was valued at US$ 5567 million in the year 2024 and is projected to reach a revised size of US$ 7058 million by 2031, growing at a CAGR of 3.5% during the forecast period.

Pertussis Vaccination Market

Pertussis Vaccination Market

Pertussis vaccine is a vaccine that protects against whooping cough. There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell vaccine is about 78% effective while the acellular vaccine is 71–85% effective.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pertussis Vaccination, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pertussis Vaccination.
The Pertussis Vaccination market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pertussis Vaccination market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pertussis Vaccination manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Pertussis Vaccination Market Report

Report Metric Details
Report Name Pertussis Vaccination Market
Accounted market size in year US$ 5567 million
Forecasted market size in 2031 US$ 7058 million
CAGR 3.5%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Acellular Vaccines
  • Whole-cell Vaccines
Segment by Application
  • 12 Months Below
  • 12 Months Above
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, KM Biologics, Wuhan Institute of Biological Products, Walvax Biotechnology, Chengdu Institute of Biological Products, Minhai Biotechnology
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Pertussis Vaccination manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Pertussis Vaccination in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Pertussis Vaccination Market growing?

Ans: The Pertussis Vaccination Market witnessing a CAGR of 3.5% during the forecast period 2025-2031.

What is the Pertussis Vaccination Market size in 2031?

Ans: The Pertussis Vaccination Market size in 2031 will be US$ 7058 million.

Who are the main players in the Pertussis Vaccination Market report?

Ans: The main players in the Pertussis Vaccination Market are Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, KM Biologics, Wuhan Institute of Biological Products, Walvax Biotechnology, Chengdu Institute of Biological Products, Minhai Biotechnology

What are the Application segmentation covered in the Pertussis Vaccination Market report?

Ans: The Applications covered in the Pertussis Vaccination Market report are 12 Months Below, 12 Months Above

What are the Type segmentation covered in the Pertussis Vaccination Market report?

Ans: The Types covered in the Pertussis Vaccination Market report are Acellular Vaccines, Whole-cell Vaccines

Recommended Reports

Pertussis and DTP Vaccines

Vaccine Technology and Devices

Broader Vaccine Markets

1 Pertussis Vaccination Market Overview
1.1 Product Definition
1.2 Pertussis Vaccination by Type
1.2.1 Global Pertussis Vaccination Market Value Comparison by Type (2024 VS 2031)
1.2.2 Acellular Vaccines
1.2.3 Whole-cell Vaccines
1.3 Pertussis Vaccination by Application
1.3.1 Global Pertussis Vaccination Market Value by Application (2024 VS 2031)
1.3.2 12 Months Below
1.3.3 12 Months Above
1.4 Global Pertussis Vaccination Market Size Estimates and Forecasts
1.4.1 Global Pertussis Vaccination Revenue 2020-2031
1.4.2 Global Pertussis Vaccination Sales 2020-2031
1.4.3 Global Pertussis Vaccination Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Pertussis Vaccination Market Competition by Manufacturers
2.1 Global Pertussis Vaccination Sales Market Share by Manufacturers (2020-2025)
2.2 Global Pertussis Vaccination Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Pertussis Vaccination Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Pertussis Vaccination, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pertussis Vaccination, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pertussis Vaccination, Product Type & Application
2.7 Global Key Manufacturers of Pertussis Vaccination, Date of Enter into This Industry
2.8 Global Pertussis Vaccination Market Competitive Situation and Trends
2.8.1 Global Pertussis Vaccination Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Pertussis Vaccination Players Market Share by Revenue
2.8.3 Global Pertussis Vaccination Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Pertussis Vaccination Market Scenario by Region
3.1 Global Pertussis Vaccination Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Pertussis Vaccination Sales by Region: 2020-2031
3.2.1 Global Pertussis Vaccination Sales by Region: 2020-2025
3.2.2 Global Pertussis Vaccination Sales by Region: 2026-2031
3.3 Global Pertussis Vaccination Revenue by Region: 2020-2031
3.3.1 Global Pertussis Vaccination Revenue by Region: 2020-2025
3.3.2 Global Pertussis Vaccination Revenue by Region: 2026-2031
3.4 North America Pertussis Vaccination Market Facts & Figures by Country
3.4.1 North America Pertussis Vaccination Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Pertussis Vaccination Sales by Country (2020-2031)
3.4.3 North America Pertussis Vaccination Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pertussis Vaccination Market Facts & Figures by Country
3.5.1 Europe Pertussis Vaccination Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Pertussis Vaccination Sales by Country (2020-2031)
3.5.3 Europe Pertussis Vaccination Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pertussis Vaccination Market Facts & Figures by Region
3.6.1 Asia Pacific Pertussis Vaccination Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Pertussis Vaccination Sales by Region (2020-2031)
3.6.3 Asia Pacific Pertussis Vaccination Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Pertussis Vaccination Market Facts & Figures by Country
3.7.1 Latin America Pertussis Vaccination Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Pertussis Vaccination Sales by Country (2020-2031)
3.7.3 Latin America Pertussis Vaccination Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pertussis Vaccination Market Facts & Figures by Country
3.8.1 Middle East and Africa Pertussis Vaccination Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Pertussis Vaccination Sales by Country (2020-2031)
3.8.3 Middle East and Africa Pertussis Vaccination Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pertussis Vaccination Sales by Type (2020-2031)
4.1.1 Global Pertussis Vaccination Sales by Type (2020-2025)
4.1.2 Global Pertussis Vaccination Sales by Type (2026-2031)
4.1.3 Global Pertussis Vaccination Sales Market Share by Type (2020-2031)
4.2 Global Pertussis Vaccination Revenue by Type (2020-2031)
4.2.1 Global Pertussis Vaccination Revenue by Type (2020-2025)
4.2.2 Global Pertussis Vaccination Revenue by Type (2026-2031)
4.2.3 Global Pertussis Vaccination Revenue Market Share by Type (2020-2031)
4.3 Global Pertussis Vaccination Price by Type (2020-2031)
5 Segment by Application
5.1 Global Pertussis Vaccination Sales by Application (2020-2031)
5.1.1 Global Pertussis Vaccination Sales by Application (2020-2025)
5.1.2 Global Pertussis Vaccination Sales by Application (2026-2031)
5.1.3 Global Pertussis Vaccination Sales Market Share by Application (2020-2031)
5.2 Global Pertussis Vaccination Revenue by Application (2020-2031)
5.2.1 Global Pertussis Vaccination Revenue by Application (2020-2025)
5.2.2 Global Pertussis Vaccination Revenue by Application (2026-2031)
5.2.3 Global Pertussis Vaccination Revenue Market Share by Application (2020-2031)
5.3 Global Pertussis Vaccination Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Sanofi Pasteur
6.1.1 Sanofi Pasteur Company Information
6.1.2 Sanofi Pasteur Description and Business Overview
6.1.3 Sanofi Pasteur Pertussis Vaccination Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Sanofi Pasteur Pertussis Vaccination Product Portfolio
6.1.5 Sanofi Pasteur Recent Developments/Updates
6.2 GSK
6.2.1 GSK Company Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Pertussis Vaccination Sales, Revenue and Gross Margin (2020-2025)
6.2.4 GSK Pertussis Vaccination Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Mitsubishi Tanabe Pharma
6.3.1 Mitsubishi Tanabe Pharma Company Information
6.3.2 Mitsubishi Tanabe Pharma Description and Business Overview
6.3.3 Mitsubishi Tanabe Pharma Pertussis Vaccination Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Mitsubishi Tanabe Pharma Pertussis Vaccination Product Portfolio
6.3.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
6.4 KM Biologics
6.4.1 KM Biologics Company Information
6.4.2 KM Biologics Description and Business Overview
6.4.3 KM Biologics Pertussis Vaccination Sales, Revenue and Gross Margin (2020-2025)
6.4.4 KM Biologics Pertussis Vaccination Product Portfolio
6.4.5 KM Biologics Recent Developments/Updates
6.5 Wuhan Institute of Biological Products
6.5.1 Wuhan Institute of Biological Products Company Information
6.5.2 Wuhan Institute of Biological Products Description and Business Overview
6.5.3 Wuhan Institute of Biological Products Pertussis Vaccination Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Wuhan Institute of Biological Products Pertussis Vaccination Product Portfolio
6.5.5 Wuhan Institute of Biological Products Recent Developments/Updates
6.6 Walvax Biotechnology
6.6.1 Walvax Biotechnology Company Information
6.6.2 Walvax Biotechnology Description and Business Overview
6.6.3 Walvax Biotechnology Pertussis Vaccination Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Walvax Biotechnology Pertussis Vaccination Product Portfolio
6.6.5 Walvax Biotechnology Recent Developments/Updates
6.7 Chengdu Institute of Biological Products
6.7.1 Chengdu Institute of Biological Products Company Information
6.7.2 Chengdu Institute of Biological Products Description and Business Overview
6.7.3 Chengdu Institute of Biological Products Pertussis Vaccination Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Chengdu Institute of Biological Products Pertussis Vaccination Product Portfolio
6.7.5 Chengdu Institute of Biological Products Recent Developments/Updates
6.8 Minhai Biotechnology
6.8.1 Minhai Biotechnology Company Information
6.8.2 Minhai Biotechnology Description and Business Overview
6.8.3 Minhai Biotechnology Pertussis Vaccination Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Minhai Biotechnology Pertussis Vaccination Product Portfolio
6.8.5 Minhai Biotechnology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pertussis Vaccination Industry Chain Analysis
7.2 Pertussis Vaccination Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pertussis Vaccination Production Mode & Process Analysis
7.4 Pertussis Vaccination Sales and Marketing
7.4.1 Pertussis Vaccination Sales Channels
7.4.2 Pertussis Vaccination Distributors
7.5 Pertussis Vaccination Customer Analysis
8 Pertussis Vaccination Market Dynamics
8.1 Pertussis Vaccination Industry Trends
8.2 Pertussis Vaccination Market Drivers
8.3 Pertussis Vaccination Market Challenges
8.4 Pertussis Vaccination Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma
KM Biologics
Wuhan Institute of Biological Products
Walvax Biotechnology
Chengdu Institute of Biological Products
Minhai Biotechnology
List of Tables
 Table 1. Global Pertussis Vaccination Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Pertussis Vaccination Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Pertussis Vaccination Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Pertussis Vaccination Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Pertussis Vaccination Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Pertussis Vaccination Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Pertussis Vaccination Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Pertussis Vaccination Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Pertussis Vaccination, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Pertussis Vaccination, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Pertussis Vaccination, Product Type & Application
 Table 12. Global Key Manufacturers of Pertussis Vaccination, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Pertussis Vaccination by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pertussis Vaccination as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Pertussis Vaccination Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Pertussis Vaccination Sales by Region (2020-2025) & (K Units)
 Table 18. Global Pertussis Vaccination Sales Market Share by Region (2020-2025)
 Table 19. Global Pertussis Vaccination Sales by Region (2026-2031) & (K Units)
 Table 20. Global Pertussis Vaccination Sales Market Share by Region (2026-2031)
 Table 21. Global Pertussis Vaccination Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Pertussis Vaccination Revenue Market Share by Region (2020-2025)
 Table 23. Global Pertussis Vaccination Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Pertussis Vaccination Revenue Market Share by Region (2026-2031)
 Table 25. North America Pertussis Vaccination Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Pertussis Vaccination Sales by Country (2020-2025) & (K Units)
 Table 27. North America Pertussis Vaccination Sales by Country (2026-2031) & (K Units)
 Table 28. North America Pertussis Vaccination Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Pertussis Vaccination Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Pertussis Vaccination Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Pertussis Vaccination Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Pertussis Vaccination Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Pertussis Vaccination Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Pertussis Vaccination Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Pertussis Vaccination Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Pertussis Vaccination Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Pertussis Vaccination Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Pertussis Vaccination Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Pertussis Vaccination Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Pertussis Vaccination Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Pertussis Vaccination Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Pertussis Vaccination Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Pertussis Vaccination Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Pertussis Vaccination Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Pertussis Vaccination Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Pertussis Vaccination Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Pertussis Vaccination Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Pertussis Vaccination Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Pertussis Vaccination Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Pertussis Vaccination Sales (K Units) by Type (2020-2025)
 Table 51. Global Pertussis Vaccination Sales (K Units) by Type (2026-2031)
 Table 52. Global Pertussis Vaccination Sales Market Share by Type (2020-2025)
 Table 53. Global Pertussis Vaccination Sales Market Share by Type (2026-2031)
 Table 54. Global Pertussis Vaccination Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Pertussis Vaccination Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Pertussis Vaccination Revenue Market Share by Type (2020-2025)
 Table 57. Global Pertussis Vaccination Revenue Market Share by Type (2026-2031)
 Table 58. Global Pertussis Vaccination Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Pertussis Vaccination Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Pertussis Vaccination Sales (K Units) by Application (2020-2025)
 Table 61. Global Pertussis Vaccination Sales (K Units) by Application (2026-2031)
 Table 62. Global Pertussis Vaccination Sales Market Share by Application (2020-2025)
 Table 63. Global Pertussis Vaccination Sales Market Share by Application (2026-2031)
 Table 64. Global Pertussis Vaccination Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Pertussis Vaccination Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Pertussis Vaccination Revenue Market Share by Application (2020-2025)
 Table 67. Global Pertussis Vaccination Revenue Market Share by Application (2026-2031)
 Table 68. Global Pertussis Vaccination Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Pertussis Vaccination Price (US$/Unit) by Application (2026-2031)
 Table 70. Sanofi Pasteur Company Information
 Table 71. Sanofi Pasteur Description and Business Overview
 Table 72. Sanofi Pasteur Pertussis Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Sanofi Pasteur Pertussis Vaccination Product
 Table 74. Sanofi Pasteur Recent Developments/Updates
 Table 75. GSK Company Information
 Table 76. GSK Description and Business Overview
 Table 77. GSK Pertussis Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. GSK Pertussis Vaccination Product
 Table 79. GSK Recent Developments/Updates
 Table 80. Mitsubishi Tanabe Pharma Company Information
 Table 81. Mitsubishi Tanabe Pharma Description and Business Overview
 Table 82. Mitsubishi Tanabe Pharma Pertussis Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Mitsubishi Tanabe Pharma Pertussis Vaccination Product
 Table 84. Mitsubishi Tanabe Pharma Recent Developments/Updates
 Table 85. KM Biologics Company Information
 Table 86. KM Biologics Description and Business Overview
 Table 87. KM Biologics Pertussis Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. KM Biologics Pertussis Vaccination Product
 Table 89. KM Biologics Recent Developments/Updates
 Table 90. Wuhan Institute of Biological Products Company Information
 Table 91. Wuhan Institute of Biological Products Description and Business Overview
 Table 92. Wuhan Institute of Biological Products Pertussis Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Wuhan Institute of Biological Products Pertussis Vaccination Product
 Table 94. Wuhan Institute of Biological Products Recent Developments/Updates
 Table 95. Walvax Biotechnology Company Information
 Table 96. Walvax Biotechnology Description and Business Overview
 Table 97. Walvax Biotechnology Pertussis Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Walvax Biotechnology Pertussis Vaccination Product
 Table 99. Walvax Biotechnology Recent Developments/Updates
 Table 100. Chengdu Institute of Biological Products Company Information
 Table 101. Chengdu Institute of Biological Products Description and Business Overview
 Table 102. Chengdu Institute of Biological Products Pertussis Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Chengdu Institute of Biological Products Pertussis Vaccination Product
 Table 104. Chengdu Institute of Biological Products Recent Developments/Updates
 Table 105. Minhai Biotechnology Company Information
 Table 106. Minhai Biotechnology Description and Business Overview
 Table 107. Minhai Biotechnology Pertussis Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Minhai Biotechnology Pertussis Vaccination Product
 Table 109. Minhai Biotechnology Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. Pertussis Vaccination Distributors List
 Table 113. Pertussis Vaccination Customers List
 Table 114. Pertussis Vaccination Market Trends
 Table 115. Pertussis Vaccination Market Drivers
 Table 116. Pertussis Vaccination Market Challenges
 Table 117. Pertussis Vaccination Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Pertussis Vaccination
 Figure 2. Global Pertussis Vaccination Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Pertussis Vaccination Market Share by Type: 2024 & 2031
 Figure 4. Acellular Vaccines Product Picture
 Figure 5. Whole-cell Vaccines Product Picture
 Figure 6. Global Pertussis Vaccination Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Pertussis Vaccination Market Share by Application: 2024 & 2031
 Figure 8. 12 Months Below
 Figure 9. 12 Months Above
 Figure 10. Global Pertussis Vaccination Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Pertussis Vaccination Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Pertussis Vaccination Sales (2020-2031) & (K Units)
 Figure 13. Global Pertussis Vaccination Average Price (US$/Unit) & (2020-2031)
 Figure 14. Pertussis Vaccination Report Years Considered
 Figure 15. Pertussis Vaccination Sales Share by Manufacturers in 2024
 Figure 16. Global Pertussis Vaccination Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Pertussis Vaccination Players: Market Share by Revenue in Pertussis Vaccination in 2024
 Figure 18. Pertussis Vaccination Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Pertussis Vaccination Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Pertussis Vaccination Sales Market Share by Country (2020-2031)
 Figure 21. North America Pertussis Vaccination Revenue Market Share by Country (2020-2031)
 Figure 22. United States Pertussis Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Pertussis Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Pertussis Vaccination Sales Market Share by Country (2020-2031)
 Figure 25. Europe Pertussis Vaccination Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Pertussis Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Pertussis Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Pertussis Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Pertussis Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Pertussis Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Pertussis Vaccination Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Pertussis Vaccination Revenue Market Share by Region (2020-2031)
 Figure 33. China Pertussis Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Pertussis Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Pertussis Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Pertussis Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Pertussis Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Pertussis Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Indonesia Pertussis Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Thailand Pertussis Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Malaysia Pertussis Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America Pertussis Vaccination Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Pertussis Vaccination Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico Pertussis Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil Pertussis Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina Pertussis Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Pertussis Vaccination Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Pertussis Vaccination Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Pertussis Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Pertussis Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Pertussis Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Pertussis Vaccination by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Pertussis Vaccination by Type (2020-2031)
 Figure 54. Global Pertussis Vaccination Price (US$/Unit) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Pertussis Vaccination by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Pertussis Vaccination by Application (2020-2031)
 Figure 57. Global Pertussis Vaccination Price (US$/Unit) by Application (2020-2031)
 Figure 58. Pertussis Vaccination Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Global Pertussis Vaccine Market Insights Forecast to 2030
Global Pertussis Treatment Market Research Report 2024
Global DTaP and Tdap Vaccines Market Insights Forecast to 2030
Global Diphtheria Tetanus and Pertussis DTaP Vaccine Market Research Report 2024
Global Diphtheria Tetanus Pertussis Vaccine Market Research Report 2025
Global Combined Polio Vaccine Market Research Report 2024
Global Whooping Cough Treatment Market Research Report 2025
Global Pediatric Preventable Vaccine Market Research Report 2024
Diphtheria Tetanus and Acellular Pertussis Combined Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Whooping Cough Preventable Vaccine Market Research Report 2024
Global Pertussis Booster Vaccine Market Research Report 2024
Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Research Report 2024
Global Maternal Pertussis Vaccine for Newborn Protection Market Research Report 2024
Global Bordetella Pertussis ELISA Kits Market Research Report 2024
Global Bordetella Pertussis Test Kit Market Research Report 2024
Global Polio Vaccination Market Research Report 2025
Global Poliomyelitis Vaccine Market Research Report 2025
Global Veterinary Vaccination Market Research Report 2025
Global Pneumococcal Vaccination Market Research Report 2025
Diphtheria Tetanus Pertussis Mix Vaccine for Children Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions